These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17513747)

  • 1. CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue.
    Connick E; Mattila T; Folkvord JM; Schlichtemeier R; Meditz AL; Ray MG; McCarter MD; Mawhinney S; Hage A; White C; Skinner PJ
    J Immunol; 2007 Jun; 178(11):6975-83. PubMed ID: 17513747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.
    Connick E; Folkvord JM; Lind KT; Rakasz EG; Miles B; Wilson NA; Santiago ML; Schmitt K; Stephens EB; Kim HO; Wagstaff R; Li S; Abdelaal HM; Kemp N; Watkins DI; MaWhinney S; Skinner PJ
    J Immunol; 2014 Dec; 193(11):5613-25. PubMed ID: 25362178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microanatomic relationships between CD8+ cells and HIV-1-producing cells in human lymphoid tissue in vivo.
    Folkvord JM; Anderson DM; Arya J; MaWhinney S; Connick E
    J Acquir Immune Defic Syndr; 2003 Apr; 32(5):469-76. PubMed ID: 12679696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.
    Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lifton MA; Lord CI; Forman MA; Letvin NL
    J Immunol; 1999 May; 162(9):5127-33. PubMed ID: 10227983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms.
    Folkvord JM; Armon C; Connick E
    AIDS Res Hum Retroviruses; 2005 May; 21(5):363-70. PubMed ID: 15929698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.
    Coles RM; Mueller SN; Heath WR; Carbone FR; Brooks AG
    J Immunol; 2002 Jan; 168(2):834-8. PubMed ID: 11777979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B-Cell Follicle in HIV Infection: Barrier to a Cure.
    Bronnimann MP; Skinner PJ; Connick E
    Front Immunol; 2018; 9():20. PubMed ID: 29422894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects.
    Shacklett BL; Beadle TJ; Pacheco PA; Grendell JH; Haslett PA; King AS; Ogg GS; Basuk PM; Nixon DF
    AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1157-62. PubMed ID: 10954891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and migration of protective CD8+ T cells into the nervous system following ocular herpes simplex virus-1 infection.
    Lang A; Nikolich-Zugich J
    J Immunol; 2005 Mar; 174(5):2919-25. PubMed ID: 15728503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
    Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
    J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication.
    Honda K; Zheng N; Murakoshi H; Hashimoto M; Sakai K; Borghan MA; Chikata T; Koyanagi M; Tamura Y; Gatanaga H; Oka S; Takiguchi M
    Eur J Immunol; 2011 Jan; 41(1):97-106. PubMed ID: 21182081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
    Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA
    J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction.
    Brainard DM; Tager AM; Misdraji J; Frahm N; Lichterfeld M; Draenert R; Brander C; Walker BD; Luster AD
    J Virol; 2007 Aug; 81(16):8439-50. PubMed ID: 17553894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy.
    Tenner-Racz K; Stellbrink HJ; van Lunzen J; Schneider C; Jacobs JP; Raschdorff B; Grosschupff G; Steinman RM; Racz P
    J Exp Med; 1998 Mar; 187(6):949-59. PubMed ID: 9500797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL.
    Yang OO; Sarkis PT; Trocha A; Kalams SA; Johnson RP; Walker BD
    J Immunol; 2003 Oct; 171(7):3718-24. PubMed ID: 14500671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease.
    Brodie SJ
    J Leukoc Biol; 2000 Sep; 68(3):351-9. PubMed ID: 10985251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.
    Blackbourn DJ; Mackewicz CE; Barker E; Hunt TK; Herndier B; Haase AT; Levy JA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13125-30. PubMed ID: 8917555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
    Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
    J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells.
    Gray CM; Lawrence J; Ranheim EA; Vierra M; Zupancic M; Winters M; Altman J; Montoya J; Zolopa A; Schapiro J; Haase AT; Merigan TC
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1357-69. PubMed ID: 11018855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.